U.S. High Court Won’t Review Discovery Order In Generic Drug MDL

Mealey's (June 15, 2020, 1:11 PM EDT) -- WASHINGTON, D.C. — The U.S. Supreme Court on June 15 denied a motion by generic drug manufacturers to review an antitrust multidistrict litigation court’s order that they produce documents even if the defendants think the documents are irrelevant or nonresponsive (Actavis Holdco US, Inc., et al. v. Connecticut, et al., No. 19-1010, U.S. Sup.)....